Eccogene (ECCO12 HK)

Eccogene is a clinical stage biopharmaceutical company developing best-in-class small molecule therapeutics for cardiometabolic and inflammatory conditions. Since its founding, the Company has been dedicated to discovering safer and more effective oral therapies that can be used alone or synergistically with a GLP-1 receptor agonist to treat conditions beyond weight management.